Research showed that cannabidiol-based Epidiolex is effective in significantly reducing seizures in hard-to-treat epilepsy. Patients above two years old with Dravet and Lennox-Gastaut syndrome had 50 percent drop in seizure frequency.
Medicine May 5, 2019
The first FDA-approved cannabis-based medication is finally available across the United States. Epidiolex is an oral solution that is approved for use in patients 2 years and older.
Medicine November 4, 2018
An FDA advisory committee gave the go-ahead for Epidiolex, a marijuana-based drug that treats two rare and severe forms of epilepsy. The FDA is scheduled to vote this June.
Medicine April 20, 2018